Penny Stock Cannabis Science Inc. (CBIS) down Sharply in Early Trading Today
Shares of Cannabis Science Inc. (OTC: CBIS), a medical marijuana company, are falling sharply in today’s trading session. At last check, the penny stock is trading 13.73% lower
The penny stock of Cannabis Science ended Wednesday 8.51% higher at $0.0510, with volume up from daily average of 18.57 million to 26.64 million. In the last three trading sessions, the penny stock gained 43.66%.
Cannabis Science shares have been gaining momentum after the company announced earlier this week that it signed a major multi-company acquisition agreement that will boost revenues, strengthen pharmaceutical operations and its management team.
Cannabis Science signed a licensing agreement with Apothecary Genetics, a cannabis seed breeding company. Under the terms of the agreement, Apothecary will produce several Cannabis Science Brand Formulations for the California medical cannabis market.
Cannabis Science also acquired GGECO University, an online video-based medical cannabis education system.
Dr. Robert Melamede, president and CEO of Cannabis Science, said that the deals put the company in a very strong position to grow quickly.
- This newsletter has been helping traders make a killing on CBIS. Click here for a 25% discount offer.
- See today’s top stock picks and market analysis
- Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
- Want more? Check out the message board buzz for CBIS
- See what newsletters are recommending this stock pick
- Get breaking news alerts on these stocks: http://thestockmarketwatch.com/
Posted by Tammy Dugas
on Thursday, February 16th, 2012. Filed under Internet, Technology.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry
This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Tech24.org is a wholly-owned subsidiary of BlueWave Advisors.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
© 2012
